Antisplicing oligonucleotides are a method of ribonucleic acid modulation and are increasingly being used to regulate protein expression in a multitude of diseases (i.e., from Alzheimer's disease to progressive supranuclear palsy, targeting tau). The gene discussed is MAPT; the disease is Classical progressive supranuclear palsy.